Ambu A/S (OTCMKTS:AMBBY) Shares Gap Up - Here's Why

Key Points

• Ambu A/S shares experienced a gap up in price, opening at $14.39 after closing the previous day at $13.73.
• UBS Group upgraded Ambu A/S shares to a "strong-buy" rating, signaling increased investor confidence.
• The company holds a market cap of $3.38 billion and has a low debt-to-equity ratio of 0.08, indicating strong financial health.

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY - Get Free Report)'s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $13.73, but opened at $14.39. Ambu A/S shares last traded at $14.39, with a volume of 500 shares traded.

Analyst Upgrades and Downgrades

Separately, UBS Group raised shares of Ambu A/S to a "strong-buy" rating in a report on Tuesday, May 13th.

Ambu A/S Stock Up 4.6%

The company has a debt-to-equity ratio of 0.08, a current ratio of 2.88 and a quick ratio of 1.67. The stock's fifty day simple moving average is $15.11 and its 200-day simple moving average is $16.56. The stock has a market cap of $3.38 billion, a P/E ratio of 75.61 and a beta of 0.89.

Ambu A/S Company Profile

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.